Hendrik Geldenhuys

Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial

Adam Penn‐Nicholson, Michèle Tameris, Erica Smit et al. · The Lancet Respiratory Medicine · 2018 · 149 citations

Veterinary Medicine, Immunology, Infectious Diseases +15

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial

Tracey A. Day, Adam Penn‐Nicholson, Angelique Kany Kany Luabeya et al. · The Lancet Respiratory Medicine · 2020 · 103 citations

Veterinary Medicine, Immunology, Infectious Diseases +10

A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or <i>Mycobacterium tuberculosis</i> –infected Adults

Thomas J. Scriba, Michèle Tameris, Erica Smit et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 86 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Dose-Finding Study of the Novel Tuberculosis Vaccine, MVA85A, in Healthy BCG-Vaccinated Infants

Thomas J. Scriba, Michèle Tameris, Nazma Mansoor et al. · The Journal of Infectious Diseases · 2011 · 84 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults

Mark Hatherill, Hendrik Geldenhuys, Bernadette Pienaar et al. · Vaccine · 2014 · 45 citations

Life Sciences, Immunology, Immunotherapy +3